IntErvention Trial of Prepare – IT

The goal of the trial was to assess the safety and efficacy of icosapent ethyl (IPE) on reducing infection rate among participants at high risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The trial took place under the observation of the Government of Argentina and (a Non-Profit Organization in Canada).

Patient Register - The Covid suffered or ongoing covid patients were registered for trial and they were provided medication. Then, doctors checked the pros and cons of the medication and record the data on the data list “Prepare - IT”

Our case studies

See all projects

Get new blog posts by email: